Pulmatrix

Clinical-stage biopharmaceutical company developing inhaled therapies for serious lung diseases using its proprietary iSPERSE technology platform for optimized pulmonary drug delivery.

Location
Lexington, Massachusetts, USA
Founded
2003
Investors
1
Categories
biotech, respiratory, drug-delivery, pulmonary-diseases

Investors

NameLocationTypeStagesPortfolio
Polaris PartnersUSbiotech-focused-33